Publications by authors named "Eric Lovett"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

23,111

Total Likes

274

Extended Reach

67,967

Social Features

11
A
Association of changes in optical coherence tomography metrics with changes in refractive error in patients with neovascular age-related macular degeneration in the CATT.
Matthew R Starr, Eric A Lovett, Rachel Israilevich, Jason Hsu, Peiying Hua

Can J Ophthalmol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on diagnosis and management of radiation retinopathy.
Eric A Lovett, Jason Fan, Basil K Williams, Maura Di Nicola

Curr Opin Ophthalmol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on "Cell Therapy" Clinics Offering Treatments of Ocular Conditions Using Direct-To-Consumer Marketing Websites in the U.S.
Meghana Kalavar, Eric A Lovett, Matthew P Nicholas, Adam Ross-Hirsch, Rajinder S Nirwan

Am J Ophthalmol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thirteen-Year Follow-Up of Conjunctival Amyloidosis.
Eric A Lovett, Thomas M Catapano, Carol L Shields

JAMA Ophthalmol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Hypoglossal Nerve Stimulation for Patients With Obstructive Sleep Apnea: A Randomized Clinical Trial.
Alan R Schwartz, Ofer Jacobowitz, David W Eisele, Samuel A Mickelson, Mitchell B Miller, Eric G Lovett

JAMA Otolaryngol Head Neck Surg· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and rationale for the treating Obstructive Sleep Apnea using Targeted Hypoglossal Nerve Stimulation (OSPREY) trial.
Ofer Jacobowitz, Alan R Schwartz, Eric G Lovett, Giovanni Ranuzzi, Atul Malhotra

Contemp Clin Trials· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction.
Fred A Weaver, William T Abraham, William C Little, Christian Butter, Anique Ducharme, Eric G Lovett

Semin Thorac Cardiovasc Surg· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems.
Rolf Wachter, Marcel Halbach, George L Bakris, John D Bisognano, Hermann Haller, Eric G Lovett

J Am Soc Hypertens· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure.
Edoardo Gronda, GianMaria Brambilla, Gino Seravalle, Alessandro Maloberti, Matteo Cairo, Eric Lovett

Clin Res Cardiol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
Michael R Zile, William T Abraham, Fred A Weaver, Christian Butter, Anique Ducharme, Eric G Lovett

Eur J Heart Fail· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction.
Edoardo Gronda, Gino Seravalle, Fosca Quarti Trevano, Giuseppe Costantino, Andrea Casini, Eric G Lovett

J Hypertens· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.
William T Abraham, Michael R Zile, Fred A Weaver, Christian Butter, Anique Ducharme, Eric G Lovett

JACC Heart Fail· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilateral or unilateral stimulation for baroreflex activation therapy.
Peter W de Leeuw, Teba Alnima, Eric Lovett, Domenic Sica, John Bisognano

Hypertension· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.
Edoardo Gronda, Gino Seravalle, Gianmaria Brambilla, Giuseppe Costantino, Andrea Casini, Eric G Lovett

Eur J Heart Fail· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Striking improvement in a case of reduced ejection fraction heart failure with baroreflex activation therapy.
Edoardo Gronda, Gianmaria Brambilla, Eric G Lovett, Giuseppe Costantino, Dimitrios Georgakpoulos

J Cardiol Cases· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The baroreceptor as a therapeutic target for heart failure.
Edoardo Gronda, Eric G Lovett, Michela Tarascio, Dimitrios Georgakopoulos, Guido Grassi

J Cardiovasc Transl Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of Barostim therapy for the treatment of resistant hypertension in European settings.
Oleg Borisenko, Joachim Beige, Eric G Lovett, Uta C Hoppe, Staffan Bjessmo

J Hypertens· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial.
Uta C Hoppe, Mathias-Christoph Brandt, Rolf Wachter, Joachim Beige, Lars Christian Rump, Eric G Lovett

J Am Soc Hypertens· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.
George L Bakris, Mitra K Nadim, Hermann Haller, Eric G Lovett, Jill E Schafer

J Am Soc Hypertens· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved cardiac structure and function with chronic treatment using an implantable device in resistant hypertension: results from European and United States trials of the Rheos system.
John D Bisognano, Christopher L Kaufman, David S Bach, Eric G Lovett, Peter de Leeuw

J Am Coll Cardiol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic baroreflex activation by the Rheos system: an overview of results from European and North American feasibility studies.
Eric G Lovett, Jill Schafer, Christopher L Kaufman

Annu Int Conf IEEE Eng Med Biol Soc· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of electrical stimulation of the carotid sinus baroreflex using the Rheos device on ventricular-vascular coupling and myocardial efficiency assessed by pressure-volume relations in non-vagotomized anesthetized dogs.
Dimitrios Georgakopoulos, Darrell Wagner, Adam W Cates, Eric Irwin, Eric G Lovett

Annu Int Conf IEEE Eng Med Biol Soc· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced rhythm discrimination for implantable cardioverter defibrillators using electrogram vector timing and correlation.
Michael R Gold, Stephen R Shorofsky, Julie A Thompson, Jaeho Kim, Mark Schwartz, Eric G Lovett

J Cardiovasc Electrophysiol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis